Table 3. Linear Regression of Predictors of Change at Week 12.

	Univariate		Multivariate
	Coefficient (95% CI)	P value	Coefficient (95% CI)	P value
<TC>
Age < 65 vs. ≥ 65	-1.2 (-7.5, 5.2)	0.719
Sex male vs. female	-3.7 (-9.9, 2.5)	0.243
BMI < 25 vs. ≥ 25	-1.0 (-7.2, 5.3)	0.765
Mets vs. non-Mets	-4.4 (-11.3, 2.5)	0.214
TC ≥ 220 vs. < 220	-15.3 (-26.3, -4.3)	0.007	-8.6 (-22.8, 5.6)	0.238
LDL-C ≥120 vs. <120	-11.8 (-21.1, -2.6)	0.012	-6.1 (-17.9, 5.7)	0.309
HDL-C ≥ 40 vs. < 40	-3.2 (-12.1, 5.7)	0.481
TG ≥ 150 vs. < 150	-9.4 (-15.4, -3.4)	0.002	-7.0 (-12.8, 1.1)	0.02
Statin strong vs. mild	-7.8 (-14.3, -1.4)	0.017	-8.6 (-14.6, -2.6)	0.005
<LDL-C>
Age < 65 vs. ≥ 65	-2.1 (-9.5, 5.3)	0.582
Sex male vs. female	-5.8 (-13.1, 1.5)	0.120
BMI < 25 vs. ≥ 25	0.1 (-7.3, 7.5)	0.976
Mets vs. non-Mets	-7.1 (-15.2, 1.0)	0.085
TC ≥ 220 vs. < 220	-14.5 (-27.6, -1.4)	0.031	-2.0 (-1.87, 14.7)	0.817
LDL-C ≥ 120 vs. < 120	-14.5 (-25.4, -3.7)	0.009	-11.9 (-25.8, 2.0)	0.095
HDL-C ≥ 40 vs. < 40	-0.5 (-11.0, 10.1)	0.932
TG ≥ 150 vs. < 150	-12.0 (-19.0, -5.0)	0.001	-9.7 (-16.6, -2.8)	0.006
Statin strong vs. mild	-8.7 (-16.3, 1.1)	0.025	-9.5 (-16.5, -2.4)	0.008
<Non-HDL-C>
Age < 65 vs. ≥ 65	-0.4 (-8.0, 7.2)	0.916
Sex male vs. female	-4.7 (-12.2, 2.8)	0.222
BMI < 25 vs. ≥ 25	-2.4 (-9.9, 5.2)	0.540
Mets vs. non-Mets	-5.6 (-13.9, 2.8)	0.190
TC ≥ 220 vs. < 220	-18.8 (-32.0, -5.5)	0.005	-5.8 (-23.1, 11.6)	0.515
LDL-C ≥ 120 vs. < 120	-16.7 (-27.7, -5.7)	0.003	-9.6 (-24.0, 4.8)	0.191
HDL-C ≥ 40 vs. < 40	0.0 (-10.8, 10.8)	0.998
TG ≥ 150 vs. < 150	-13.3 (-20.4, -6.2)	0	-11.1 (-18.2, -3.9)	0.002
Statin strong vs. mild	-6.6 (-14.4,1.3)	0.103